ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer
Abstract We have identified endoplasmic reticulum oxidoreductase 1 alpha (ERO1A) as a poor prognostic indicator in epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (EGFR MUT-NSCLC). In addition, comparison of high versus low ERO1A expression among cohorts of EGFR MUT-NSCLC...
Saved in:
| Main Authors: | M. A. Voronkova, B. Johnson, N. Gandhi, J. M. Koomen, M Patrick, S. Shanthi Bhupathi, V. M. Wu, A. Elliott, A. Vanderwalde, B. Halmos, L. A. Hazlehurst |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-024-00736-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eros electrónico
by: Sofina Dembruk
Published: (2024-12-01) -
Eros and education
by: John Crutchfield
Published: (2024-10-01) -
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms
by: Jiannong Li, et al.
Published: (2013-11-01) -
Éros el memorioso
by: María Angélica Fierro
Published: (2020-11-01) -
Profiling of driver mutations in lung adenocarcinoma patients identifies rare compound EGFR mutations sensitive to second-generation EGFR-TKIs
by: Jun Li, et al.
Published: (2024-12-01)